Refractory pityriasis rubra pilaris treated with abrocitinib

Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic therapies failed.

Authors

Institutions

Publication Details

Journal
Dermatology Reports
Published
2025-01-09
DOI
https://doi.org/10.4081/dr.2025.10105
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob
1 links
Dermatology Reports
Psoriasis: Treatment and Pathogenesis
article

Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob
article en

Abstract

Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic therapies failed.

Dermatology ReportsVol. 17(3)
Charles University (CZ)
Openalex Percentile: Top 100%
Psoriasis: Treatment and Pathogenesis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Refractory pityriasis rubra pilaris treated with abrocitinib — Filip Rob · Dermatology Reports (2025) | TGRS Research Map | TGRS